Carolinas HealthCare System

Research and Clinical Trials

Title  
ALLSTAR
Brief Description  
The purpose of this study is to examine the safety of intracoronary (into the coronary artery related to the heart attack) infusion of allogeneic cardiosphere-derived cells 4 weeks to 12 months following a heart attack.
Who may be Eligible  
Patients being considered for participation are those who have had a heart attack between 30 days and one year prior to enrollment.
Start Date  
10/07/2015
IRB Number  
10-15-12A
Principal Investigator  
Kowalchuk, Glen
Contact Name  
Sally

For More Information, Contact   Sally  Krueger , RN
Phone:  (704) 355-4797  Fax:  (704) 355-7264 
Email:  SHVIClinicalResearch@carolinashealthcare.org
Address:  1001 Blythe Blvd., MCP M-201
Charlotte, NC 28203
Close